Somaxon Pharmaceuticals, Inc. Names James L’Italien, Ph.D. Senior Vice President, Regulatory Affairs and Quality Assurance

SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced the appointment of James L’Italien, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance, a newly created position.